The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biological chemistry

• Publication date

  2015-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1515/hsz-2014-0192PMID 25252751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A

  2013cited by this paper
• Impact of serum amyloid A on cellular cholesterol efflux to serum in type 2 diabetes mellitus.

  2013cited by this paper
• The relationship between serum amyloid A and apolipoprotein A‐I in high‐density lipoprotein isolated from patients with coronary heart disease

  2013cited by this paper
• Serum amyloid A activation of human coronary artery endothelial cells exhibits a neutrophil promoting molecular profile.

  2013cited by this paper
• Comparative Genomic Insights Into the Biosynthesis and Regulation of Mycobacterial Siderophores

  2013cited by this paper
• Sphingosine 1-Phosphate in Renal Diseases

  2013cited by this paper
• Serum amyloid A stimulates macrophage foam cell formation via lectin-like oxidized low-density lipoprotein receptor 1 upregulation.

  2013cited by this paper
• Role of formyl peptide receptor 2 on the serum amyloid A-induced macrophage foam cell formation.

  2013cited by this paper
• Crystal Structure of a Lipid G Protein–Coupled Receptor

  2012cited by this paper
• Sphingosine 1-Phosphate (S1P) Carrier-dependent Regulation of Endothelial Barrier

  2012cited by this paper
• Serum amyloid A in uremic HDL promotes inflammation.

  2012cited by this paper
• Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes

  2012cited by this paper
• High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.

  2012cited by this paper
• Pharmacological relevance and potential of sphingosine 1‐phosphate in the vascular system

  2011cited by this paper
• Serum Amyloid A Directly Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice

  2011cited by this paper
• Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.

  2011cited by this paper
• The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein.

  2011influential reference
• Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M

  2011influential reference
• Serum amyloid A in atherosclerosis

  2011cited by this paper
• Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

  2011cited by this paper
• Serum amyloid A induces reactive oxygen species (ROS) production and proliferation of fibroblast

  2011cited by this paper
• Serum Amyloid A Activates the NLRP3 Inflammasome via P2X7 Receptor and a Cathepsin B-Sensitive Pathway

  2011cited by this paper
• A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A.

  2010cited by this paper
• CD36 Is a Novel Serum Amyloid A (SAA) Receptor Mediating SAA Binding and SAA-induced Signaling in Human and Rodent Cells*

  2010cited by this paper
• A pertussis toxin sensitive G-protein-independent pathway is involved in serum amyloid A-induced formyl peptide receptor 2-mediated CCL2 production

  2010cited by this paper
• Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2[S]

  2010cited by this paper
• Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease

  2010cited by this paper
• Influence of Apolipoprotein (Apo) A-I Structure on Nascent High Density Lipoprotein (HDL) Particle Size Distribution*

  2010cited by this paper
• The paraoxonase gene family and atherosclerosis

  2009cited by this paper
• Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer.

  2009cited by this paper
• Secretory Phospholipase A2, Group IIA Is a Novel Serum Amyloid A Target Gene

  2009cited by this paper
• Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

  2009cited by this paper
• Inflammation Impairs Reverse Cholesterol Transport In Vivo

  2009cited by this paper
• Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes.

  2009cited by this paper
• Serum amyloid A may potentiate prothrombotic and proinflammatory events in acute coronary syndromes.

  2009cited by this paper
• Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I

  2009cited by this paper
• Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2.

  2009cited by this paper
• In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.

  2009cited by this paper
• Defining lipid-binding regions of human serum amyloid A using its fragment peptides.

  2009cited by this paper
• High-density lipoprotein subclasses distribution and composition in Mexican adolescents with low HDL cholesterol and/or high triglyceride concentrations, and its association with insulin and C-reactive protein.

  2008cited by this paper
• High Density Lipoprotein-associated Sphingosine 1-Phosphate Promotes Endothelial Barrier Function*

  2008cited by this paper
• Principles of bioactive lipid signalling: lessons from sphingolipids

  2008cited by this paper
• Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A1

  2008cited by this paper
• Is serum amyloid A an endogenous TLR4 agonist?

  2008cited by this paper
• Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7‐sensitive pathway independent of formyl peptide receptor‐like 1

  2008cited by this paper
• The ability of HDL to inhibit VCAM-1 expression and oxidized LDL uptake is impaired in renal patients.

  2008cited by this paper
• Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.

  2008cited by this paper
• HDL-Associated Lysosphingolipids Inhibit NAD(P)H Oxidase–Dependent Monocyte Chemoattractant Protein-1 Production

  2008cited by this paper
• Effects of torcetrapib in patients at high risk for coronary events.

  2007cited by this paper
• Association between serum lipids and survival in hemodialysis patients and impact of race.

  2007cited by this paper
• Endothelial and antithrombotic actions of HDL.

  2006cited by this paper
• Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation.

  2006influential reference
• Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient.

  2006cited by this paper
• The paraoxonase gene family and atherosclerosis.

  2005cited by this paper
• Serum Amyloid A Promotes Cholesterol Efflux Mediated by Scavenger Receptor B-I*

  2005cited by this paper
• Relationship between plasma lipid concentrations and HDL subclasses.

  2005cited by this paper
• Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells.

  2005cited by this paper
• Serum Amyloid A Is a Ligand for Scavenger Receptor Class B Type I and Inhibits High Density Lipoprotein Binding and Selective Lipid Uptake*

  2005cited by this paper
• Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.

  2004cited by this paper
• Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro Published, JLR Papers in Press, November 1, 2003. DOI 10.1194/jlr.M300414-JLR200

  2004cited by this paper
• HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

  2004cited by this paper
• Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells.

  2004cited by this paper
• Atheroprotective effects of high-density lipoproteins.

  2003cited by this paper
• High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.

  2003cited by this paper
• Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1 Published, JLR Papers in Press, September 1, 2003. DOI 10.1194/jlr.M300133-JLR200

  2003cited by this paper
• Serum paraoxonase activity decreases in rheumatoid arthritis.

  2003cited by this paper
• Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response.

  2003cited by this paper
• Identification and Characterization of a Novel Human Sphingosine-1-phosphate Phosphohydrolase, hSPP2*

  2003cited by this paper
• Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors.

  2002cited by this paper
• Impaired capacity of acute-phase high density lipoprotein particles to deliver cholesteryl ester to the human HUH-7 hepatoma cell line.

  2002cited by this paper
• Characterization of Murine Sphingosine-1-phosphate Phosphohydrolase*

  2002cited by this paper
• HDL and arteriosclerosis: beyond reverse cholesterol transport.

  2002cited by this paper
• International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature

  2002cited by this paper
• Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1.

  2002cited by this paper
• Proinflammatory Cytokines But Not Acute Phase Serum Amyloid A Or C-Reactive Protein, Downregulate Paraoxonase 1 (Pon1) Expression By Hepg2 Cells

  2002cited by this paper
• The role of high-density lipoproteins in oxidation and inflammation.

  2001cited by this paper
• Sphingosine 1-Phosphate Protects Human Umbilical Vein Endothelial Cells from Serum-deprived Apoptosis by Nitric Oxide Production*

  2001cited by this paper
• Role of serum amyloid A during metabolism of acute-phase HDL by macrophages.

  2000cited by this paper
• Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions.

  2000cited by this paper
• High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway

  1999cited by this paper
• Atheroprotective mechanisms of HDL.

  1999cited by this paper
• Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate.

  1999cited by this paper
• Human Serum Amyloid A has Cytokine‐Like Properties

  1998cited by this paper
• Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1.

  1998cited by this paper
• Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts.

  1998cited by this paper
• Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions

  1996cited by this paper
• Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells.

  1996cited by this paper
• HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease.

  1996cited by this paper
• Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.

  1995cited by this paper
• Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

  1995cited by this paper
• Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux.

  1995cited by this paper
• Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.

  1995cited by this paper
• Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification.

  1994cited by this paper
• Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function.

  1994cited by this paper
• Human serum amyloid A genes are expressed in monocyte/macrophage cell lines.

  1994cited by this paper
• Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes

  1994cited by this paper
• Serum amyloid A (SAA): an acute phase protein and apolipoprotein.

  1993cited by this paper
• Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens

  1993cited by this paper
• Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function.

  1992cited by this paper
• Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol acyltransferase.

  1992cited by this paper

• METTL13 mediated SAA1 translation maintains cancer stem cell behavior and promotes esophageal carcinoma progression.

  2026cites this paper
• Insights to HDL dysfunctionality: hypothesis of exhausted HDL.

  2026cites this paper
• Ceramide-based machine learning models for the diagnosis of unstable angina: a prospective multicenter study

  2026cites this paper
• The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target

  2024cites this paper
• Multi-omics with dynamic network biomarker algorithm prefigures organ-specific metastasis of lung adenocarcinoma

  2024cites this paper
• Lipid levels and risk of acute pancreatitis using bidirectional Mendelian randomization

  2024cites this paper
• SAA1 identified as a potential prediction biomarker for metastasis of hepatocellular carcinoma via multi-omics approaches

  2023cites this paper
• Dyslipidemia in rheumatoid arthritis: the possible mechanisms

  2023cites this paper
• Hepatocytic lipocalin-2 controls HDL metabolism and atherosclerosis via Nedd4-1-SR-BI axis in mice.

  2023cites this paper
• Investigating the Relationship between Obstructive Sleep Apnoea, Inflammation and Cardio-Metabolic Diseases

  2023cites this paper
• Relationship between Cholesterol-Related Lipids and Severe Acute Pancreatitis: From Bench to Bedside

  2023cites this paper
• Signal Transduction and Gene Regulation in the Endothelium.

  2022cites this paper
• High-density lipoprotein cholesterol efflux capacity in patients with obstructive sleep apnea and its relation with disease severity

  2022cites this paper
• Dengue virus NS1 protein conveys pro‐inflammatory signals by docking onto high‐density lipoproteins

  2022cites this paper
• Deoxysphingolipids Upregulate MMP-1, Downregulate TIMP-1, and Induce Cytotoxicity in Human Schwann Cells

  2021cites this paper
• The dengue virus NS1 protein conveys pro-inflammatory signals by docking onto human high-density lipoproteins

  2021cites this paper
• Stressing the Endothelium to Assess Localized Inflammatory Potential and the Risk for Atherosclerotic Cardiovascular Disease.

  2021cites this paper
• High SAA1 Expression Predicts Advanced Tumors in Renal Cancer

  2021cites this paper
• New insights into the emerging effects of inflammatory response on HDL particles structure and function

  2021cites this paper
• Is a High HDL-Cholesterol Level Always Beneficial?

  2021cites this paper
• High density lipoprotein in atherosclerosis and coronary heart disease: Where do we stand today?

  2021cites this paper
• Fibronectin-containing High-Density Lipoprotein is Associated with Cancer Cell Adhesion and Proliferation.

  2020cites this paper
• Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk

  2020cites this paper
• High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?

  2020cites this paper
• Dysfunctional HDLs are Associated with a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested-Case Control Study

  2020cites this paper
• Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects

  2020cites this paper
• Discussion on the Effectiveness of Elevating HDL-C in Treating Cardiovascular Diseases of Patients with Type 2 Diabetes Mellitus

  2019cites this paper
• Sphingosine 1-phosphate and inflammation.

  2019cites this paper
• Dysfunctional HDLs are Associated with a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested-Case Control Study.

  2019cites this paper
• Progress in Research on Nonalcoholic Fatty Liver and Gestational Diabetes

  2019cites this paper
• High Density Lipoproteins Phosphatidylcholine as a Regulator of Reverse Cholesterol Transport

  2018cites this paper
• Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease.

  2018cites this paper
• Dynamic changes of the composition of plasma HDL particles in patients with cardiac disease: Spotlight on sphingosine‐1‐phosphate/serum amyloid A ratio

  2018cites this paper
• The effect of chronic kidney disease on lipid metabolism

  2018cites this paper
• Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate

  2017cites this paper
• Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease

  2017cites this paper
• Could high-density lipoprotein cholesterol predict increased cardiovascular risk?

  2017cites this paper
• Angiopoietin‐Like Protein 4 Is a High‐Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type‐2 Diabetic Patients

  2017cites this paper
• and function Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction patient-oriented and epidemiological research

  2017cites this paper
• Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction[S]

  2017cites this paper
• Lipid Disorders in CKD: nature and underlying molecular mechanisms 3.1. Dyslipidemia of CKD and ESRD 3.1.1. Alterations in triglyceride and triglyceride-rich lipoprotein metabolism 3.1.2. Alterations in cholesterol and low density lipoprotein metabolism

  2017cites this paper
• Effect of inflammation on HDL structure and function

  2016cites this paper
• Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients

  2016cites this paper
• HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation

  2016cites this paper
• HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications

  2015cites this paper